BDRX P/E Ratio
P/E Ratio as of Oct 28, 2025: -0.10
Average-0.1145
Median-0.1100
Minimum-0.1700
Maximum-0.1000
-0.10
Past Month0.00 (0.00%)
The P/E ratio for BDRX is -0.10 as of Oct 28, 2025. This represents a decrease of -83.05% compared to its 12-month average P/E ratio of -0.59. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Biodexa Pharmaceuticals Plc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Biodexa Pharmaceuticals Plc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Biodexa Pharmaceuticals Plc to industry peers.
Biodexa Pharmaceuticals Plc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Biodexa Pharmaceuticals Plc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Biodexa Pharmaceuticals Plc to industry peers.
BDRX P/E Ratio Insights
See Biodexa Pharmaceuticals Plc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in BDRX
Order type
Buy in
Order amount
Est. shares
0 shares
BDRX P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2025 | $6.61 | -0.10 |
| Sep 2, 2025 | $5.36 | -0.03 |
| Aug 1, 2025 | $6.70 | -0.04 |
| Jul 1, 2025 | $8.699 | -0.50 |
| Jun 2, 2025 | $11.50 | -0.66 |
| May 1, 2025 | $14.10 | -0.81 |
| Apr 1, 2025 | $12.00 | -0.24 |
| Mar 3, 2025 | $29.50 | -0.59 |
| Feb 3, 2025 | $43.10 | -0.87 |
| Jan 2, 2025 | $40.90 | -0.82 |
BDRX End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2025 | -0.10 | -87.65% |
| 2024 | -0.81 | +1,925.00% |
| 2023 | -0.04 | -99.27% |
| 2022 | -5.46 | -1.80% |
| 2021 | -5.56 | +569.88% |
| 2020 | -0.83 | — |
FAQs About Biodexa Pharmaceuticals Plc (BDRX) P/E ratio
The latest P/E ratio of BDRX is -0.10, as of Oct 28, 2025. This is calculated based on its current stock price and earnings per share (EPS).
Biodexa Pharmaceuticals Plc’s last 12-month average P/E ratio is -0.59, compared to its current P/E ratio of -0.10. This reflects a decrease of -83.05%.
Biodexa Pharmaceuticals Plc’s current P/E ratio of -0.10 is lower than its last 12-month average P/E of -0.59. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Biodexa Pharmaceuticals Plc’s average P/E ratio over the last 3 years is -1.37. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Biodexa Pharmaceuticals Plc’s average P/E ratio over the last 5 years is -2.91. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.